Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre studyThomas F. Stoop, Jin He, Atsushi Oba et al.|British Journal of Cancer|2025Cited by 8